P55055 (NR1H2_HUMAN) Homo sapiens (Human)
Oxysterols receptor LXR-beta UniProtKBInterProSTRINGInteractive Modelling
460 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA |
Heteromer P19793; Q15596; | 100.0 | 1×9CR; 4×ZN; 1×965; | |||
| Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease |
Heteromer P28702; | 98.35 | 1×668; 1×PEG; | |||
| Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazo… |
Heteromer P28702; | 98.72 | 1×6Y4; | |||
| Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists |
Heteromer P28702; Q15596; | 98.36 | 1×67S; | |||
| X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol |
Heteromer Q15788; | 100.0 | 1×CO1; | |||
| Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazo… |
Heteromer P28702; | 98.35 | 1×6Y8; | |||
| X-ray crystal structure of a Potent Liver X Receptor Modulator |
Heteromer Q15596; | 97.12 | 1×G58; | |||
| Crystal structure of LXR ligand binding domain in complex with full agonist 1 |
Heteromer Q15788; | 100.0 | 2×0KS; 1×ACT; 7×CA; | |||
| Crystal structure of LXR ligand binding domain in complex with partial agonist 5 |
Heteromer Q15788; | 100.0 | 2×0KT; 1×ACT; 6×CA; | |||
| Human LXR-beta in complex with an agonist | homo-2-mer | 99.54 | 2×D40; | |||
| Human LXR-beta in complex with a ligand | homo-2-mer | 99.14 | 1×BQ3; | |||
| Human LXR-beta in complex with an agonist | homo-2-mer | 99.14 | 2×D43; | |||
| Human LXR-beta in complex with an agonist | homo-2-mer | 98.33 | 2×D3R; | |||
| Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial … | homo-2-mer | 100.0 | 3×BU1; 2×652; | |||
| HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX | homo-2-mer | 100.0 | 2×965; 2×IPA; | |||
| HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX | homo-2-mer | 100.0 | 2×BNS; 2×44B; | |||
| CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-8… | homo-2-mer | 100.0 | 2×6OX; 1×BU1; | |||
| Complex Structure of LXR with an agonist | homo-2-mer | 100.0 | 2×61X; | |||
| HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 | homo-2-mer | 100.0 | 2×444; | |||
| Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthe… | monomer | 100.0 | 1×444; | |||
| Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthe… | monomer | 100.0 | 1×444; | |||
| LXRbeta ligand binding domain in complex with small molecule inhibitors | monomer | 100.0 | 1×KWE; | |||
| LXRbeta ligand binding domain in comlpex with small molecule inhibitors | monomer | 100.0 | 3×KUW; | |||
| LXRbeta ligand binding domain in comlpex with small molecule inhibitors | monomer | 100.0 | 2×KVB; | |||
| LXRbeta ligand binding domain in comlpex with small molecule inhibitors | monomer | 100.0 | 1×KVK; | |||
9 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4nqa.2.B | monomer | 0.76 | 2×ZN; 1×965; | 98.70 | ||
| 4nqa.1.B | monomer | 0.75 | 2×ZN; 1×965; | 98.70 | ||
| 5uan.1.B | monomer | 0.64 | 1×ZN; | 35.14 | ||
| 3dzy.1.B | monomer | 0.60 | 1×ZN; | 30.36 | ||
| 4nqa.1.A | monomer | 0.59 | 2×ZN; | 28.00 | ||
| 4iqr.2.A | monomer | 0.57 | 2×ZN; | 29.47 | ||
| 7prv.1.B | monomer | 0.57 | 2×ZN; | 23.95 | ||
| 5uan.1.A | monomer | 0.56 | 1×ZN; | 28.00 | ||
| 4iqr.2.B | monomer | 0.55 | 2×ZN; | 29.47 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4nqa.1.B | monomer | 0.77 | 1×965; | 92.38 | ||
| Isoform 2 | 4nqa.2.B | monomer | 0.75 | 1×965; | 92.38 | ||